13F 申報指南13F 觀念全攻略
什麼是 SEC Form 13F 申報？美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
AlphaSMO 權威研究指南閱讀專題
CIK: 0001920938
申報總市值
US$27.0億
US$27.0億
81 檔
26.9%
根據最新整理的 13F 季度數據集，Braidwell LP 於 Q3 2024 結束時的管理資產規模為 US$27.0億。該機構在本季度申報了 81 檔美股持倉，呈現出該時期的主要投資地圖。
Braidwell LP 在 Q3 2024 進行了結構性的板塊輪動與部位換股。在開立 16 個全新部位及加碼 26 檔持股的同時，亦同步清倉 10 檔並減碼 24 檔標的。
檢視投資組合結構，前 5 大主力部位（包含 GH 0 11-15-27, BBIO 2.5 03-15-27, NVCR 0 11-01-25）占據了總市值的 26.9%，展現出該機構在 Q3 2024 的重點資金聚焦與風險分佈特徵。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH 0 11-15-27債券 | Guardant Health Inc | 債券 | 6.12% | — | — | |
| 2 | BBIO 2.5 03-15-27債券 | Bridgebio Pharma Inc | 債券 | 4.13% | — | — | |
| 3 | NVCR 0 11-01-25債券 | Novocure LTD | 債券 | 3.78% | — | — | |
| 4 | CGON | Cg Oncology Inc | 股票-其他 | 3.39% | -2.22% | EXIT | |
| 5 | GMED 0.375 03-15-25債券 | Nuvasive Inc | 債券 | 3.17% | — | — | |
| 6 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 3.02% | -0.07% | +5.73% | |
| 7 | NBIX | Neurocrine Biosciences Inc | 股票-醫療保健 | 3.00% | -0.77% | +20.90% | |
| 8 | NEO 0.25 01-15-28債券 | Neogenomics Inc | 債券 | 2.75% | -2.44% | — | |
| 9 | APGE | Apogee Therapeutics Inc | 股票-其他 | 2.74% | -1.34% | EXIT | |
| 10 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 2.55% | — | +410.82% | |
| 11 | IRWD 1.5 06-15-26債券 | Ironwood Pharmaceuticals | 債券 | 2.34% | — | +3.34% | |
| 12 | DXCM 0.375 05-15-28債券 | Dexcom Inc | 債券 | 2.33% | — | +12.09% | |
| 13 | ALGN | Align Technology Inc | 股票-醫療保健 | 2.25% | — | +13.25% | |
| 14 | GH | Guardant Health Inc | 股票-醫療保健 | 2.17% | -0.72% | +19.02% | |
| 15 | PODD 0.375 09-01-26債券 | Insulet Corporation | 債券 | 2.17% | — | -6.18% | |
| 16 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 2.13% | — | -7.68% | |
| 17 | VKTX | Viking Therapeutics Inc | 股票-醫療保健 | 2.08% | — | +4.52% | |
| 18 | KNSA | Kiniksa Pharmaceuticals International, plc | 股票-其他 | 2.05% | -0.01% | +40.63% | |
| 19 | PEN | Penumbra Inc | 股票-醫療保健 | 1.99% | -1.15% | EXIT | |
| 20 | DXCM 0.25 11-15-25債券 | Dexcom Inc | 債券 | 1.99% | — | — | |
| 21 | MRVI | Maravai Lifesciences Hldgs-a | 股票-其他 | 1.97% | +1.04% | -7.43% | |
| 22 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 1.92% | — | +60.54% | |
| 23 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.83% | +1.32% | -12.91% | |
| 24 | RGEN | Repligen CORP | 股票-醫療保健 | 1.67% | +0.70% | +22.65% | |
| 25 | IRTC | Irhythm Holdings Inc | 股票-醫療保健 | 1.65% | +0.48% | +48.67% | |
| 26 | TVTX 2.5 09-15-25債券 | Travere Therapeutics Inc | 債券 | 1.52% | — | — | |
| 27 | ATEC 0.75 08-01-26債券 | Alphatec Holdings Inc | 債券 | 1.49% | — | — | |
| 28 | ARGX | Argenx Se - Adr | 股票-醫療保健 | 1.49% | -1.46% | -42.06% | |
| 29 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 1.48% | +0.53% | — | |
| 30 | INSP | Inspire Medical Systems Inc | 股票-醫療保健 | 1.43% | -0.05% | -37.04% | |
| 31 | SRPT | Sarepta Therapeutics Inc | 股票-醫療保健 | 1.31% | — | +352.26% | |
| 32 | BBIO 2.25 02-01-29債券 | Bridgebio Pharma Inc | 債券 | 1.28% | — | -18.29% | |
| 33 | ISRG | Intuitive Surgical Inc | 股票-醫療保健 | 1.27% | -0.16% | -9.15% | |
| 34 | ✓ | Avadel Pharmaceuticals PLC ADR | 股票-其他 | 1.26% | — | +16.91% | |
| 35 | BCAX | Bicara Therapeutics Inc | 股票-其他 | 1.20% | — | — | |
| 36 | KROS | Keros Therapeutics Inc | 股票-其他 | 1.16% | — | -28.00% | |
| 37 | GKOS | Glaukos CORP | 股票-醫療保健 | 1.15% | +0.32% | -37.25% | |
| 38 | MDGL | Madrigal Pharmaceuticals Inc | 股票-醫療保健 | 1.11% | — | — | |
| 39 | PCVX | Vaxcyte Inc | 股票-其他 | 0.96% | — | -63.19% | |
| 40 | REPL | Replimune Group Inc | 股票-其他 | 0.95% | — | +203.03% | |
| 41 | ARVN | Arvinas Inc | 股票-其他 | 0.90% | — | +148.34% | |
| 42 | KRYS | Krystal Biotech Inc | 股票-醫療保健 | 0.87% | +0.20% | +57.39% | |
| 43 | KIDS | Orthopediatrics CORP | 股票-其他 | 0.85% | +0.20% | — | |
| 44 | DXCM | Dexcom Inc | 股票-醫療保健 | 0.84% | — | — | |
| 45 | BNTX | Biontech Se-adr | 股票-其他 | 0.83% | — | — | |
| 46 | FNAUSD | Paragon 28 Inc | 股票-其他 | 0.78% | — | -0.36% | |
| 47 | RLAY | Relay Therapeutics Inc | 股票-其他 | 0.70% | — | +16.38% | |
| 48 | ATEC | Alphatec Holdings Inc | 股票-其他 | 0.64% | +1.30% | +84.11% | |
| 49 | HROW | Harrow Inc | 股票-其他 | 0.56% | -0.18% | EXIT | |
| 50 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 0.56% | — | +567.62% |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | APLSUSD | Apellis Pharmaceuticals Inc | +1.8% | +410.82% | 加碼 |
| 2 | EWTX | Edgewise Therapeutics Inc | +1.5% | NEW | 新建倉 |
| 3 | BCAX | Bicara Therapeutics Inc | +1.2% | NEW | 新建倉 |
| 4 | MDGL | Madrigal Pharmaceuticals Inc | +1.1% | NEW | 新建倉 |
| 5 | SRPT | Sarepta Therapeutics Inc | +0.9% | +352.26% | 加碼 |
| 6 | KNSA | Kiniksa Pharmaceuticals International, plc | +0.8% | +40.63% | 加碼 |
| 7 | DXCM | Dexcom Inc | +0.8% | NEW | 新建倉 |
| 8 | BNTX | Biontech Se-adr | +0.8% | NEW | 新建倉 |
| 9 | PEN | Penumbra Inc | +0.8% | +70.01% | 加碼 |
| 10 | REPL | Replimune Group Inc | +0.7% | +203.03% | 加碼 |
| 11 | DAWNGBX | Day One Biopharmaceuticals I | +0.6% | +60.54% | 加碼 |
| 12 | AMPH 2 03-15-29債券 | Amphastar Pharmaceutical | +0.6% | NEW | 新建倉 |
| 13 | ✓ | Immatics NV | +0.5% | NEW | 新建倉 |
| 14 | ARVN | Arvinas Inc | +0.5% | +148.34% | 加碼 |
| 15 | CGEM | Cullinan Therapeutics Inc | +0.5% | +567.62% | 加碼 |
| 16 | BSX | Boston Scientific CORP | +0.5% | NEW | 新建倉 |
| 17 | RGEN | Repligen CORP | +0.4% | +22.65% | 加碼 |
| 18 | HROW | Harrow Inc | +0.4% | +47.93% | 加碼 |
| 19 | ORKA | Oruka Therapeutics Inc | +0.4% | NEW | 新建倉 |
| 20 | ✓ | Zura Bio LTD | +0.3% | NEW | 新建倉 |
| 21 | PODD | Insulet CORP | +0.3% | NEW | 新建倉 |
| 22 | XNCR | Xencor Inc | +0.3% | NEW | 新建倉 |
| 23 | JSPR | Jasper Therapeutics Inc | +0.3% | NEW | 新建倉 |
| 24 | KRYS | Krystal Biotech Inc | +0.3% | +57.39% | 加碼 |
| 25 | VKTX | Viking Therapeutics Inc | +0.2% | +4.52% | 加碼 |
| 26 | OCUL | Ocular Therapeutix Inc | +0.2% | +36.26% | 加碼 |
| 27 | ALGN | Align Technology Inc | +0.2% | +13.25% | 加碼 |
| 28 | FDMT | 4d Molecular Therapeutics In | +0.1% | +231.69% | 加碼 |
| 29 | CGON | Cg Oncology Inc | +0.1% | -4.19% | 減碼 |
| 30 | FULC | Fulcrum Therapeutics Inc | +0.1% | NEW | 新建倉 |
| 31 | CELC | Celcuity Inc | +0.1% | +71.16% | 加碼 |
| 32 | ✓ | Verve Therapeutics Inc | +0.1% | NEW | 新建倉 |
| 33 | RLAY | Relay Therapeutics Inc | +0.1% | +16.38% | 加碼 |
| 34 | DNTH | Dianthus Therapeutics Inc | +0.1% | +34.57% | 加碼 |
| 35 | ✓ | Hillevax Inc | +0.1% | NEW | 新建倉 |
| 36 | LUNG | Pulmonx CORP | 0% | — | 不變 |
| 37 | TVTX 2.5 09-15-25債券 | Travere Therapeutics Inc | 0% | — | 不變 |
| 38 | CSTL | Castle Biosciences Inc | 0% | -20.21% | 減碼 |
| 39 | SYRE | Spyre Therapeutics Inc | 0% | -12.91% | 減碼 |
| 40 | ✓ | Avadel Pharmaceuticals PLC ADR | 0% | +16.91% | 加碼 |
| 41 | CUTR 4 06-01-29債券 | Cutera Inc | 0% | — | 不變 |
| 42 | ✓ | Dbv Technologies S A | 0% | -33.24% | 減碼 |
| 43 | HAE 0 03-01-26債券 | Haemonetics CORP | 0% | — | 不變 |
| 44 | ETNBGBP | 89bio Inc | 0% | EXIT | 清倉 |
| 45 | BBIO | Bridgebio Pharma Inc | -0.1% | -13.65% | 減碼 |
| 46 | CUTR 2.25 06-01-28債券 | Cutera Inc | -0.1% | — | 不變 |
| 47 | ALEC | Alector Inc | -0.1% | -9.34% | 減碼 |
| 48 | MRVI | Maravai Lifesciences Hldgs-a | -0.1% | -7.43% | 減碼 |
| 49 | OMGBP | Outset Medical Inc | -0.1% | EXIT | 清倉 |
| 50 | ATEC | Alphatec Holdings Inc | -0.1% | +84.11% | 加碼 |
根據 SEC 官方 Form 13F 申報備案，Braidwell LP 在 Q3 2024 季度的美股持倉總市值約為 US$27.0億，共申報了 81 個公開持股部位。
在 Q3 2024 季度，Braidwell LP 按市值排列的前三大核心持股分別為：GH 0 11-15-27 (6.1%)、BBIO 2.5 03-15-27 (4.1%)、NVCR 0 11-01-25 (3.8%)。其中最大持股部位 GH 0 11-15-27 佔據整體投資組合約 6.1% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析，提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
EWTX
市值: US$5226.7萬
本季最大獲利了結 / 清倉標的
SRPT 1.25 09-15-27
前期市值: US$5551.2萬
在 Q3 2024 季度中，Braidwell LP 共進行了 76 項持倉異動，包含新建倉 16 個部位、加碼 26 個部位、減碼 24 個部位以及清倉 10 個部位。 其中最大新建倉標的為 EWTX。 本季清倉部位包含 SRPT 1.25 09-15-27。
本頁面所有持股數據均直接同步自美國證券交易委員會（SEC）EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照，提供 100% 精準對齊的歷史時序數據集，並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報，掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異，以及最新 SEC 申報時程規範，洞察機構法人的激進投資動向。